Thursday , 12 March 2015

Latest News
Home » Business & Finance » Climbing Stocks Investor’s Alert - Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (NASDAQ:GPOR)
Climbing Stocks Investor’s Alert – Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (NASDAQ:GPOR)

Climbing Stocks Investor’s Alert - Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (NASDAQ:GPOR)

March 12, 2015 1:00 pm by: Category: Business & Finance Leave a comment A+ / A-

On Wednesday, Following U.S. Stocks were among the “Top Gainers”: Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (NASDAQ:GPOR)

Kythera Biopharmaceuticals, (NASDAQ:KYTH), with shares inclined 6.14%, closed at $52.02.

Barnes & Noble, (NYSE:BKS), with shares jumped 6.08%, settled at $23.72.

Gulfport Energy, (NASDAQ:GPOR), with shares climbed 5.32%, and closed at $44.53.

Latest NEWS regarding these Stocks are depicted underneath:

Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)

Kythera Biopharmaceuticals, Inc. (KYTH), declared the pricing of its underwritten public offering of 2,604,168 shares of its ordinary stock at a price to the public of $48.00 per share, before underwriting discounts and commissions and expenses of the offering, for gross proceeds of about $125 million. All of the shares of the ordinary stock sold in the offering were offered by KYTHERA. In addition, KYTHERA granted the underwriters a 30-day option to purchase up to an additional 390,625 shares.

KYTHERA intends to use the substantial majority of the net proceeds of the offering to fund the ongoing development and preparation for potential commercialization of ATX-101, and the balance for working capital and general corporate purposes, counting research and development, which may comprise repayments of outstanding amounts under KYTHERA’s credit facility.

The offering is predictable to close on March 16, 2015, subject to satisfaction of customary closing conditions.

Goldman, Sachs & Co., BofA Merrill Lynch, and Leerink Partners acted as the joint book-running managers for the offering. Cowen and Corporation acted as co-manager.

KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical corporation, focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally.

Barnes & Noble, Inc. (NYSE:BKS)

Barnes & Noble, Inc. (BKS), stated sales and earnings for its fiscal 2015 third quarter ended January 31, 2015.

Third quarter merged proceeds of $1.96 billion declined $35 million as contrast to the preceding year. Third quarter merged earnings before interest, taxes, depreciation and amortization (EBITDA) raised 14% as contrast to the preceding year to $197 million.

Third Quarter 2015 Results from Operations:

College:

The College segment had proceeds of $521 million, increasing 7.2% as contrast to a year ago. In addition to new store growth, third quarter sales benefitted from a later shift in the fiscal calendar. The quarter ended on January 31st this year, as contrast to January 25th last year, and, therefore, comprised of an additional week of the spring back-to-school rush season.

For the comparable sales period, comparable College store sales reduced 1.4% for the quarter. The spring back-to-school rush season extended past the close of the Corporation’s fiscal third quarter. Factoring in the two additional weeks in February that contributed to this year’s rush season, comparable store sales reduced 1.0%. Comparable sales comparisons are not influenced by the calendar timing difference noted above.

College EBITDA declined $7 million as contrast to a year ago to $28 million, as proceed growth was offset by continued investments to support business growth and the digital education platform. Margins also declined on higher textbook rental deferrals and comparisons to a preceding year favorable LIFO adjustment.

NOOK:

The NOOK segment (counting digital content, devices and accessories) had proceeds of $78 million for the quarter, decreasing 50.6% from a year ago. Device and accessories sales were $37 million for the quarter, a decrease of 62.8% from a year ago, due to lower unit selling volume. Digital content sales were $41 million for the quarter, a decline of 29.3% contrast to a year ago, due primarily to the lower device unit sales volume.

Despite the sales decline, NOOK EBITDA losses reduced $32 million, or 52.5%, as contrast to a year ago to $29 million. Margins improved on product mix and lower occupancy costs, while expenses declined on continued cost rationalization efforts.

Barnes & Noble, Inc. (BKS), operates as a content, commerce, and technology corporation in the United States. The corporation operates in three segments: B&N Retail, B&N College, and NOOK.

Gulfport Energy Corp. (NASDAQ:GPOR)

Formerly on February 25, Gulfport Energy Corp. (GPOR), stated year-end 2014 proved reserves of 933.6 Bcfe, an raise of 305% over year-end 2013.

Year-End 2014 Reserves:

Gulfport stated year-end 2014 total proved reserves of 933.6 Bcfe, comprising of 719.0 Bcf of natural gas, 9.5 MMBbl of oil, and 26.3 MMBbl of natural gas liquids. Gulfport’s year-end total proved reserves raised 305% over year-end 2013.

Proved developed reserves raised by 204% over 2013 to about 453.8 Bcfe, as of December 31, 2014. At year-end 2014, about 49% of Gulfport’s proved reserves were classified as proved developed reserves. Proved undeveloped reserves raised by 491% over 2013 to about 479.8 Bcfe, as of December 31, 2014.

Gulfport Energy Corporation engages in the attainment, exploration, exploitation, and production of natural gas, natural gas liquids (NGLs), and crude oil in the United States. In addition, Gulfport holds a sizeable acreage position in the Alberta Oil Sands in Canada through its 25% interest in Grizzly Oil Sands ULC.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

Climbing Stocks Investor’s Alert - Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (NASDAQ:GPOR) Reviewed by on . On Wednesday, Following U.S. Stocks were among the "Top Gainers": Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (N On Wednesday, Following U.S. Stocks were among the "Top Gainers": Kythera Biopharmaceuticals, (NASDAQ:KYTH), Barnes & Noble, (NYSE:BKS), Gulfport Energy, (N Rating: 0

Leave a Comment

scroll to top